Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Work In Process (2022 - 2025)

Historic Work In Process for Ekso Bionics Holdings (EKSO) over the last 4 years, with Q3 2025 value amounting to $324000.0.

  • Ekso Bionics Holdings' Work In Process rose 764.12% to $324000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $324000.0, marking a year-over-year increase of 764.12%. This contributed to the annual value of $177000.0 for FY2024, which is 3896.55% down from last year.
  • Ekso Bionics Holdings' Work In Process amounted to $324000.0 in Q3 2025, which was up 764.12% from $300000.0 recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Work In Process high stood at $751000.0 for Q2 2023, and its period low was $177000.0 during Q4 2024.
  • Moreover, its 4-year median value for Work In Process was $319000.0 (2025), whereas its average is $353818.2.
  • Its Work In Process has fluctuated over the past 5 years, first crashed by 7110.52% in 2024, then surged by 3824.88% in 2025.
  • Ekso Bionics Holdings' Work In Process (Quarter) stood at $487000.0 in 2022, then tumbled by 40.45% to $290000.0 in 2023, then plummeted by 38.97% to $177000.0 in 2024, then surged by 83.05% to $324000.0 in 2025.
  • Its last three reported values are $324000.0 in Q3 2025, $300000.0 for Q2 2025, and $319000.0 during Q1 2025.